Paroxysmal atrial fibrillation and administration of antiplatelet therapy are still negative determinants of warfarin use in non-valvular atrial fibrillation patients treated by Japanese cardiologists. [electronic resource]
- Circulation journal : official journal of the Japanese Circulation Society 2011
- 2314-5 p. digital
Publication Type: Editorial; Comment
1347-4820
10.1253/circj.cj-11-0920 doi
Atrial Fibrillation--drug therapy Female Humans International Normalized Ratio Male Platelet Aggregation Inhibitors--therapeutic use Warfarin--therapeutic use